Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials. Rolston VS, Kimmel J, Popov V, Bosworth BP, et al. Dig Dis Sci 2021;66:1631-1638.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rolston VS, Kimmel J, Popov V, Bosworth BP, et al. Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials. Dig Dis Sci 2021;66:1631-1638.
PMID: 32445049